- $31.85bn
- $36.75bn
- $5.68bn
- 99
- 14
- 69
- 64
Annual cashflow statement for Equifax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 526 | 749 | 700 | 552 | 607 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -94.8 | 114 | 25.8 | 58 | 81.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 49 | -26.3 | -626 | -42.5 | 21.9 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 946 | 1,335 | 757 | 1,117 | 1,325 |
Capital Expenditures | -421 | -469 | -625 | -601 | -512 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -71.4 | -2,929 | -335 | -277 | 0 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -493 | -3,398 | -960 | -878 | -512 |
Financing Cash Flow Items | -39 | -89.5 | -43.6 | -69.1 | -26.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 811 | 618 | 274 | -306 | -846 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,283 | -1,460 | 60.5 | -68.4 | -46.9 |